Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2021, Vol. 26 ›› Issue (10): 1159-1166.doi: 10.12092/j.issn.1009-2501.2021.10.008

Previous Articles     Next Articles

Research progress of glutamine metabolism in liver cancer

LIU Zhuo, TAN Xiaoning, ZENG Puhua   

  1. Affiliated Hospital of Hunan Academy of traditional Chinese medicine, Changsha 410006, Hunan, China
  • Received:2021-06-08 Revised:2021-08-07 Online:2021-10-26 Published:2021-11-02

Abstract: Liver cancer is one of the most dangerous malignant tumors in China. It has the characteristics of high mortality and occult onset. At present, the treatment of liver cancer is mainly targeted drugs, surgery and chemoradiotherapy, which is prone to high recurrence rate and strong drug resistance. In this paper, glutamine metabolism as the breakthrough point, the glutamine metabolism enzymes and related genes related to liver cancer are reviewed, in order to provide an open new idea for the pathogenesis and drug treatment of liver cancer.

Key words: liver cancer, glutamine metabolism, mechanism

CLC Number: